Id-1 (Inhibitor of differentiation/DNA binding) is a member of the helix–loop–helix protein
family expressed in actively proliferating cells. It regulates gene transcription by …

Androgen-independent metastatic prostate cancer is the main obstacle in the treatment of this
cancer. Unlike a majority of solid cancers, prostate cancer usually shows poor response to …

Purpose: Hepatocellular carcinoma (HCC) is a rapidly growing tumor associated with a high
propensity for vascular invasion and metastasis. Epithelial-mesenchymal transition (EMT) is …

Taxol is one of the widely used chemotherapeutic drugs against many types of human cancer.
While it is considered as one of the most effective anticancer drugs, treatment failure often …

OBJECTIVE To evaluate the effect of S‐allylcysteine (SAC) on CWR22R, a human androgen‐independent
(AI) prostate cancer xenograft, in nude mice. Despite extensive research …

Tocotrienol-rich fraction (TRF) has demonstrated antiproliferative effect on prostate cancer (PCa)
cells. To elucidate this anticancer property in PCa cells, this study aimed, first, to identify …

The growth-promoting effect of Id-1 (inhibitor of differentiation/DNA binding) has been
demonstrated in a number of human cancers. However, the mechanisms responsible for its action …

Id‐1 (inhibitor of differentiation or DNA binding) is a helix‐loop‐helix protein that is overexpressed
in many types of cancer including esophageal squamous cell carcinoma (ESCC). We …

Background Damage to a small-for-size liver graft after reperfusion is frequently observed but
the mechanism of injury remains unclear. Hypothesis Injury to a small-for-size liver graft is …

Androgen-independent metastatic prostate cancer is the main cause of cancer related
death in men. One of the reasons for this is the lack of understanding of the molecular …